AI Drug Discovery: Who Sells the Picks and Shovels?
If AI accelerates drug discovery, where does scarcity, and economic value, actually move?
AI has demonstrated meaningful productivity gains in early drug discovery. But the evidence becomes much weaker further down the development chain.
This research asks a different investment question: if AI improves discovery productivity, where does persistent scarcity emerge, and who can actually capture its economic value?
Explore Research →